SG

Soreensing Gulabsing Juni

Active Director Director DIN 07413307
DIN 07413307 First appointment Feb 2016 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Soreensing Gulabsing Juni

Data last updated:

Soreensing Gulabsing Juni is a Director at Phytology Pharma Private Limited (since 2016). The company operates in Chemicals.

DIN 07413307
Primary Designation Director
Industry Chemicals
First Appointment 08 Feb 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Phytology Pharma Private Limited U24233MH2016PTC272894
Director08 Feb 20162016Active

Board colleagues of Soreensing Gulabsing Juni

NameDINCompanyDesignation
Gurudayalsing Soransing Juni07413306Phytology Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Phytology Pharma Private Limited
Premium access

Shareholding and investment profile for Soreensing Gulabsing Juni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Soreensing Gulabsing Juni

Soreensing Gulabsing Juni currently holds 1 directorship: Phytology Pharma Private Limited (Director, since 08 Feb 2016).

Soreensing Gulabsing Juni was first appointed on 08 Feb 2016 as Director at Phytology Pharma Private Limited.

The current boards of Soreensing Gulabsing Juni's companies include Gurudayalsing Soransing Juni (Phytology Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available